Mina Swiha

Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

Mina Swiha, Duncan E. K. Sutherland, Golmehr Sistani et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 29 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Development of a Visually Calculated SUV_mean(HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to¹⁷⁷Lu-PSMA Therapy: Comparison with Quantitative SUV_meanand Patient Outcomes

Mina Swiha, Nathan Papa, Zahra Sabahi et al. · Journal of Nuclear Medicine · 2024 · 25 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database

Mohammed Abdullah Alghamdi, Carla Pires Amaro, Richard M. Lee‐Ying et al. · Cancer Medicine · 2020 · 15 citations · Full text

Medicine, Oncology, Pharmacology +13

Comparison of Posttherapy 4- and 24-Hour [¹⁷⁷Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer

Mina Swiha, Sarennya Pathmanandavel, Nathan Papa et al. · Journal of Nuclear Medicine · 2024 · 11 citations · Full text

Medicine, Nuclear Medicine, Oncology +17